(TheNewswire)
VANCOUVER, BC – TheNewswire - December 22, 2023 – Izotropic Corporation (“ Izotropic ” or the“ Company ”)(CSE: IZO ) (OTC: IZOZF )(FSE: 1R3 ), a medical device company commercializing IzoView, a CT(computed tomography) imaging system, that produces images of anatomyfor non-invasive tissue characterization with an application in breastimaging, announces the results of its Annual General Meeting andSpecial Meeting held on December 19, 2023.
Company matters submitted to shareholders for approvalas set out in the Company's Notice of Meeting and ManagementInformation Circular, dated November 17, 2023, were approved by therequisite majority of votes cast at the meeting.
The primary matters acted upon were:
-
Approval of all nominees to sit as directors of thecorporation for the ensuing year and the number of directors to be setat five;
-
Approval of the appointment of auditor Dale MathesonCarr-Hilton LaBonte LLP;
-
Re-approval of the Stock Option Plan;
-
Re-approval of the Long-term Incentive Plan.
ON BEHALF OF THE BOARD
Mr. Robert Thast, CEO
Cell: 604-220-5031
Contact:
Email: info@izocorp.com
Toll Free: 1-833-IZOCORP ext.1
About Izotropic
More information about Izotropic Corporation can befound on its website at izocorp.com and by reviewing its profile on SEDAR at sedar.com.
Forward-Looking Statements
This document may contain statements that are"Forward-Looking Statements," which are based upon thecurrent estimates, assumptions, projections, and expectations of theCompany's management, business, and its knowledge of the relevantmarket and economic environment in which it operates. The Company hastried, where possible, to identify suchinformation and statements by using words such as"anticipate," "believe," "envision,""estimate," "expect," "intend,""may," "plan," "predict,""project," "target," "potential,""will," "would," "could,""should," "continue," "contemplate" andother similar expressions and derivations thereof in connection withany discussion of future events, trends or prospects or futureoperating or financial performance, although not all forward-lookingstatements contain these identifying words.
These statements are not guarantees of performance andinvolve risks, including those related to capital requirements anduncertainties that are difficult to control or predict, and as such,they may cause future results of the Company's activity to differsignificantly from the content and implications of such statements.Forward-Looking Statements are pertinent only as of the date on whichthey are made, and the Company undertakes no obligation to update orrevise any Forward-Looking Statements to reflect new information orthe occurrence of future events or circumstances unless otherwiserequired to do so by law. Neither the Company nor its shareholders,officers, and consultants shall be liable for any action and theresults of any action taken by any person based on the informationcontained herein, including, without limitation, the purchase or saleof Company securities. Nothing in this document should be deemed to bemedical or other advice of any kind. All images are for illustrativepurposes only. IzoView is not yet approved for sale.
Copyright (c) 2023 TheNewswire - All rights reserved.